{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:22:49Z","timestamp":1793506969187,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jsat.2019.12.005","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T12:30:58Z","timestamp":1575635458000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings"],"prefix":"10.1016","volume":"110","author":[{"given":"Ang\u00e9lica","family":"Meinhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse M.","family":"Hinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2019.12.005_bb0005","author":"42 CFR \u00a7 8.12"},{"issue":"1","key":"10.1016\/j.jsat.2019.12.005_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2105\/AJPH.2018.304771","article-title":"Amphetamine-and opioid-affected births: Incidence, outcomes, and costs, United States, 2004\u20132015","volume":"109","author":"Admon","year":"2019","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.jsat.2019.12.005_bb0015","first-page":"37","article-title":"Opioid prescription claims among women of reproductive age\u2014United States, 2008\u20132012","volume":"64","author":"Ailes","year":"2015","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2019.12.005_bb0020","author":"American Society of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2019.12.005_bb0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jrh.12307","article-title":"Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: A 5-year update","volume":"35","author":"Andrilla","year":"2019","journal-title":"Journal of Rural Health"},{"issue":"1","key":"10.1016\/j.jsat.2019.12.005_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1081\/ADA-120018838","article-title":"Effectiveness of substance abuse treatment programming for women: A review","volume":"29","author":"Ashley","year":"2003","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"43","key":"10.1016\/j.jsat.2019.12.005_bb0035","first-page":"1487","article-title":"Vital signs: Overdoses of prescription opioid pain relievers\u2014United States, 1999\u20132008","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2019.12.005_bb0040","author":"Centers for Disease Control and Prevention"},{"issue":"2","key":"10.1016\/j.jsat.2019.12.005_bb0045","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1353\/hpu.2010.0174","article-title":"Women in residential drug treatment: Differences by program type and pregnancy","volume":"10","author":"Grella","year":"1999","journal-title":"Journal of Health Care for the Poor and Underserved"},{"key":"10.1016\/j.jsat.2019.12.005_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2017.01.011","article-title":"Substance use, treatment, and demographic characteristics of pregnant women entering treatment for opioid use disorder differ by United States census region","volume":"76","author":"Hand","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2019.12.005_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jsat.2011.02.004","article-title":"Long-term outcomes among drug-dependent mothers treated in women-only versus mixed-gender programs","volume":"41","author":"Hser","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.jsat.2019.12.005_bb0060","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s10995-011-0923-5","article-title":"Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky","volume":"16","author":"Jackson","year":"2012","journal-title":"Maternal and Child Health Journal"},{"key":"10.1016\/j.jsat.2019.12.005_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2017.08.001","article-title":"Maternal buprenorphine treatment and infant outcome","volume":"180","author":"Jansson","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2019.12.005_bb0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ajog.2013.10.010","article-title":"Clinical care for opioid-using pregnant and postpartum women: The role of obstetric providers","volume":"210","author":"Jones","year":"2014","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1016\/j.jsat.2019.12.005_bb0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2165\/11632820-000000000-00000","article-title":"Methadone and buprenorphine for the management of opioid dependence in pregnancy","volume":"72","author":"Jones","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jsat.2019.12.005_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: A comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2019.12.005_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: Effects on the neonatal abstinence syndrome","volume":"79","author":"Jones","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2019.12.005_bb0090","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2019.12.005_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2007.10.007","article-title":"Treatment of opioid-dependent pregnant women: Clinical and research issues","volume":"35","author":"Jones","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.12.005_bb0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.addbeh.2018.11.019","article-title":"Substance use disorder treatment admissions and state-level prenatal substance use policies: Evidence from a national treatment database","volume":"90","author":"Kozhimannil","year":"2019","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.jsat.2019.12.005_bb0105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/08897077.2016.1146649","article-title":"Factors associated with buprenorphine versus methadone use in pregnancy","volume":"37","author":"Krans","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2019.12.005_bb0110","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: Temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.jsat.2019.12.005_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy","volume":"48","author":"Martin","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.12.005_bb0120","series-title":"The National Survey on Drug Use and Health: 2017","author":"McCance-Katz","year":"2018"},{"issue":"9","key":"10.1016\/j.jsat.2019.12.005_bb0125","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamapediatrics.2019.1738","article-title":"Trends in foster care entry among children removed from their homes because of parental drug use, 2000 to 2017","volume":"173","author":"Meinhofer","year":"2019","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.jsat.2019.12.005_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhealeco.2018.06.004","article-title":"The role of health insurance on treatment for opioid use disorders: Evidence from the affordable care act Medicaid expansion","volume":"60","author":"Meinhofer","year":"2018","journal-title":"Journal of Health Economics"},{"issue":"1","key":"10.1016\/j.jsat.2019.12.005_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","article-title":"Medication treatment for opioid use disorders in substance use treatment facilities","volume":"38","author":"Mojtabai","year":"2019","journal-title":"Health Affairs"},{"issue":"1","key":"10.1016\/j.jsat.2019.12.005_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7517-9-14","article-title":"Integrated programs for mothers with substance abuse issues: A systematic review of studies reporting on parenting outcomes","volume":"9","author":"Niccols","year":"2012","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.jsat.2019.12.005_bb0145","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","volume":"119","year":"2012","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.jsat.2019.12.005_bb0150","first-page":"1","article-title":"Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states","author":"Patrick","year":"2018","journal-title":"Substance Abuse"},{"issue":"8","key":"10.1016\/j.jsat.2019.12.005_bb0155","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing patterns and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"Journal of Perinatology"},{"issue":"8","key":"10.1016\/j.jsat.2019.12.005_bb0160","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"Journal of Perinatology"},{"issue":"18","key":"10.1016\/j.jsat.2019.12.005_bb0165","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.jsat.2019.12.005_bb0170","author":"Ranji"},{"key":"10.1016\/j.jsat.2019.12.005_bb0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2018.04.003","article-title":"Trends and disparities in receipt of pharmacotherapy among pregnant women in publicly funded treatment programs for opioid use disorder in the United States","volume":"89","author":"Short","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.12.005_bb0180","author":"Smith"},{"key":"10.1016\/j.jsat.2019.12.005_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addbeh.2016.02.030","article-title":"Residential and outpatient treatment completion for substance use disorders in the US: Moderation analysis by demographics and drug of choice","volume":"58","author":"Stahler","year":"2016","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2019.12.005_bb0190","series-title":"A collaborative approach to the treatment of pregnant women with opioid use disorders. HHS publication no. (SMA) 16\u20134978","author":"Substance Abuse and Mental Health Services Administration","year":"2016"},{"key":"10.1016\/j.jsat.2019.12.005_bb0195","series-title":"Results from the 2017 National Survey on Drug Use and Health: Detailed tables","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"10.1016\/j.jsat.2019.12.005_bb0200","series-title":"Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. HHS publication no. (SMA) 18-5054","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"issue":"11","key":"10.1016\/j.jsat.2019.12.005_bb0205","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.2105\/AJPH.2015.302821","article-title":"Women-centered drug treatment services and need in the United States, 2002\u20132009","volume":"105","author":"Terplan","year":"2015","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2019.12.005_bb0210","series-title":"Guidelines for the identification and management of substance use and substance use disorders in pregnancy","author":"World Health Organization","year":"2014"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219302570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219302570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:50:35Z","timestamp":1760039435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547219302570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":42,"alternative-id":["S0740547219302570"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.12.005","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}